Cargando…

Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189478/ https://www.ncbi.nlm.nih.gov/pubmed/34106990 http://dx.doi.org/10.1371/journal.pone.0253252

Ejemplares similares

2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
por: Mohamed Amine, Msolli, et al.
Publicado: (2021)

Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial
por: Messous, Salma, et al.
Publicado: (2022)

Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’
Publicado: (2023)

Correction to: Impact of anxiety and depression on the prognosis of copd exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2022)

Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease
por: Yoon, Ho II, et al.
Publicado: (2013)

C-reactive protein-guided antibiotic prescribing for COPD exacerbations: a qualitative evaluation
por: Phillips, Rhiannon, et al.
Publicado: (2020)

Microbial Resistance to Antibiotics and Effective Antibiotherapy
por: Chiș, Adriana Aurelia, et al.
Publicado: (2022)

Correction to: Bayesian approach to investigate a two-state mixed model of COPD exacerbations
por: Largajolli, Anna, et al.
Publicado: (2019)

Author Correction: Care-seeking and delay of care during COPD exacerbations
por: Locke, Emily R., et al.
Publicado: (2022)

Correction: Serum Reactive Oxygen Metabolite Levels Predict Severe Exacerbations of Asthma
Publicado: (2016)

Antibiothérapie et asthme de l'enfant
por: Marguet, C, et al.
Publicado: (2003)

Antibiotherapy in Children with Cystic Fibrosis—An Extensive Review
por: Ciuca, Ioana Mihaiela, et al.
Publicado: (2022)

End-of-Life Antibiotherapy: Factors Associated With Prescription
por: Campoa, Elsa, et al.
Publicado: (2022)

Treatment for acute uncomplicated diverticulitis without antibiotherapy: systematic review and meta-analysis of randomized clinical trials
por: Correa Bonito, Alba, et al.
Publicado: (2023)

C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity
por: Gallego, Miguel, et al.
Publicado: (2016)

Correction to: Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
Publicado: (2023)

Correction: Differentiation of quantitative CT imaging phenotypes in asthma versus COPD
Publicado: (2018)

Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD
por: Francis, Nick A, et al.
Publicado: (2020)

Acute Exacerbation of COPD
por: Lief, Lindsay, et al.
Publicado: (2019)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Acute Exacerbation of COPD
por: Pappas, Dominic, et al.
Publicado: (2023)

Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review
por: Dubald, Marion, et al.
Publicado: (2018)

Traitement de l’appendicite par antibiothérapie seulement
por: Farooq, Ameer, et al.
Publicado: (2021)

Correction to: Respiratory support in COPD patients after acute exacerbation with monitoring the quality of support (Rescue2-monitor): an open-label, prospective randomized, controlled, superiority clinical trial comparing hospital- versus home-based acute non-invasive ventilation for patients with hypercapnic chronic obstructive pulmonary disease
Publicado: (2020)

C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations: A protocol for systematic review and meta-analysis
por: An, Xing, et al.
Publicado: (2020)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
por: Azab, Eman T., et al.
Publicado: (2022)

Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis
por: Donahoe, Michael, et al.
Publicado: (2015)

Successful Management of Prosthetic Valve Brucella Endocarditis with Antibiotherapy Alone
por: Fonseca, José Pedro, et al.
Publicado: (2018)

Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial
por: Elkhodary, Noha Mahmoud, et al.
Publicado: (2020)

Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD
por: Baalbaki, Nour, et al.
Publicado: (2022)

Correction to: Lazy Sundays: role of day of the week and reactivity on objectively measured physical activity in older people
por: Klenk, Jochen, et al.
Publicado: (2019)

Day-to-Day Variability of Parameters Recorded by Home Noninvasive Positive Pressure Ventilation for Detection of Severe Acute Exacerbations in COPD
por: Jiang, Weipeng, et al.
Publicado: (2021)

Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD
por: Echevarria, C, et al.
Publicado: (2017)

Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
por: Blasi, Francesco, et al.
Publicado: (2013)

Correction: Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Anan, Keisuke, et al.
Publicado: (2023)

Remission of chronic acne fulminans and severe hidradenitis suppurativa with targeted antibiotherapy
por: Duchatelet, Sabine, et al.
Publicado: (2019)

Renal function in patients with diabetic foot infection; does antibiotherapy affect it?
por: Akbari, Roghayeh, et al.
Publicado: (2016)

Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
por: Bruch, R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hpr64ldocp9p0g8tp6p0gbsecn